ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 1 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 519 | -16.2% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 619 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | – | 619 | +519.0% | 0.00% | – |
| Q1 2018 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 100 | -84.1% | 0.00% | – |
| Q3 2017 | $3,000 | -93.0% | 630 | -93.2% | 0.00% | -100.0% |
| Q2 2017 | $43,000 | +1333.3% | 9,290 | +1374.6% | 0.00% | – |
| Q1 2017 | $3,000 | 0.0% | 630 | 0.0% | 0.00% | – |
| Q4 2016 | $3,000 | -25.0% | 630 | +18.9% | 0.00% | – |
| Q3 2016 | $4,000 | 0.0% | 530 | 0.0% | 0.00% | – |
| Q2 2016 | $4,000 | 0.0% | 530 | +60.6% | 0.00% | – |
| Q4 2015 | $4,000 | – | 330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |